Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019
Jiaoyue Zhang, Wen Kong, Peng‐Fei Xia, Ying Xu, Li Li, Qin Li, Yang Li, Qi Wei, Hanyu Wang, Huiqing Li, Juan Zheng, Hui Sun, Wenfang Xia, Geng Liu, Xueyu Zhong, Kangli Qiu, Yan Li, Han Wang, Yuxiu Wang, Xiaoli Song, Hua Liu, Si Xiong, Yumei Liu, Zhenhai Cui, Yu Hu, Lulu Chen, An Pan, Tianshu Zeng
Abstract
<bold>Background:</bold> Diabetes correlates with poor prognosis in patients with COVID-19, but very few studies have evaluated whether impaired fasting glucose (IFG) is also a risk factor for the poor outcomes of patients with COVID-19. Here we aimed to examine the associations between IFG and diabetes at admission with risks of complications and mortality among patients with COVID-19. <bold>Methods:</bold> In this multicenter retrospective cohort study, we enrolled 312 hospitalized patients with COVID-19 from 5 hospitals in Wuhan from Jan 1 to Mar 17, 2020. Clinical information, laboratory findings, complications, treatment regimens, and mortality status were collected. The associations between hyperglycemia and diabetes status at admission with primary composite end-point events (including mechanical ventilation, admission to intensive care unit, or death) were analyzed by Cox proportional hazards regression models. <bold>Results:</bold> The median age of the patients was 57 years (interquartile range 38–66), and 172 (55%) were women. At the time of hospital admission, 84 (27%) had diabetes (and 36 were new-diagnosed), 62 (20%) had IFG, and 166 (53%) had normal fasting glucose (NFG) levels. Compared to patients with NFG, patients with IFG and diabetes developed more primary composite end-point events (9 [5%], 11 [18%], 26 [31%]), including receiving mechanical ventilation (5 [3%], 6 [10%], 21 [25%]), and death (4 [2%], 9 [15%], 20 [24%]). Multivariable Cox regression analyses showed diabetes was associated increased risks of primary composite end-point events (hazard ratio 3.53; 95% confidence interval 1.48–8.40) and mortality (6.25; 1.91–20.45), and IFG was associated with an increased risk of mortality (4.11; 1.15–14.74), after adjusting for age, sex, hospitals and comorbidities. <bold>Conclusion:</bold> IFG and diabetes at admission were associated with higher risks of adverse outcomes among patients with COVID-19.